Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Chronic Phase CML Model for Predicting Complete Cytogenetic Response to Imatinib Mesylate

MyLikes

MyPaths
Purpose:
To determine the chances of having a complete cytogenetic response following imatinib mesylate therapy in a Philadelphia chrosome positive CML in chronic phase.
Specialty
  • Hematology Oncology
Objective
  • Risk factors
ICD-10
  • C92.1
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Chronic Phase CML Model for Predicting Complete Cytogenetic Response to Imatinib Mesylate
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.